[EN] GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES<br/>[FR] AGONISTES DE GPR40 POUR LE TRAITEMENT DU DIABÈTE DE TYPE 2
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2017027312A1
公开(公告)日:2017-02-16
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (III); wherein R1c, R2C, R4C, Wc, Yc, Zc and Gc, are defined herein.
揭示了一种通过调节GPR40受体影响的疾病的化合物、组合物和治疗方法。这些化合物由公式(III)表示;其中R1c、R2C、R4C、Wc、Yc、Zc和Gc在此处定义。